Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Uroplasty to market I-STOP in US:

This article was originally published in Clinica

Executive Summary

Minneapolis, Minnesota-based Uroplasty has secured exclusive US distribution rights to the I-STOP mid-urethral sling for six years, following an agreement with the product's French developer CL Medical (Lyon) to distribute distribution of the I-STOP(TM) in the US. Uroplasty already sells the I-STOP in the UK through its wholly-owned subsidiary based in Reading, Berkshire. According to Uroplasty, the I-STOP is the only monofilament polypropylene tape specifically designed for treating female stress urinary incontinence caused by lack of urethral support (urethral hypermobility).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050936

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel